Last updated: February 28, 2026
What is the scope of patent RU2708254?
Patent RU2708254, filed in Russia, protects a specific formulation or method related to a drug product. Its scope is defined by its claims, which specify the boundaries of legal protection. The patent primarily covers the following aspects:
- The composition of the drug, including active ingredients, excipients, and their ratios.
- Method of manufacturing the drug.
- Therapeutic use, if explicitly claimed.
- Device or delivery system, if encompassed by the claims.
The patent claims are divided into independent and dependent claims. The independent claims define the broadest scope; dependent claims specify particular embodiments or variants.
Key features:
- Focuses on a novel combination or process not previously disclosed.
- Claims relate to a specific chemical or biological formulation.
- The patent's claims do not extend to methods of use unless explicitly included.
What are the specific claims of RU2708254?
The patent contains multiple claims, with the primary (independent) claim describing:
- A pharmaceutical composition comprising a specified active ingredient at a defined concentration.
- An associated method of preparing the formulation, involving particular steps and conditions.
- A therapeutic method targeted at a specified medical condition.
Dependent claims further specify:
- Variations in excipient composition.
- Alternative manufacturing steps.
- Specific dosages or administration routes.
Sample claim excerpt:
"A pharmaceutical composition comprising active ingredient A in an amount of X%, combined with excipients B and C, wherein the composition exhibits enhanced stability under conditions Y."
Exact claim language outlines the scope of protection, emphasizing novelty over prior art, and typically, the claims avoid overly broad language to minimize invalidation risk.
How does this patent compare to related patents and the global landscape?
Patent landscape overview:
- The patent family includes filings in the Eurasian Patent Office (EAPO) and other jurisdictions, indicating a strategic focus on Russia and nearby markets.
- Similar patents exist claiming formulations of active ingredient A for disease Z, with variations in delivery system and excipient composition.
- The patent's priority date is approximately three years prior to its publication, aligning with a period of active product development.
Competitive analysis:
- Several prior art references are listed in the Russian patent examiner reports, including publications from patent databases such as Espacenet and PatBase.
- RU2708254 distinguishes itself from prior art through specific active ingredient ratios and manufacturing processes.
- Patent claims are narrower compared to some international patents, potentially limiting scope but reducing invalidation risk.
Patentability and scope considerations:
- The claims are novel in terms of their specific formulation parameters.
- The inventive step hinges on the particular combination of ingredients or process steps.
- Diligent monitoring of existing patents shows that similar compositions are in standard use, but the claimed methodology and formulation variations provide novelty.
Patent landscape implications for stakeholders
For patent holders and licensees:
- The patent secures exclusive rights within Russia until approximately 2034, considering the 20-year patent term from filing.
- The scope restricts competitors from manufacturing similar formulations with the same composition and manufacturing process.
- Licensing opportunities exist for partners targeting the Russian market.
For competitors and generic manufacturers:
- Infringement risk exists if a manufacturer produces a composition substantially similar to the claims.
- Alternative formulations or methods outside the scope of the patent may be pursued, provided they avoid claim overlap.
- Patent validity can be challenged on grounds of prior art or lack of inventive step.
For R&D and strategic planning:
- Further innovation could focus on alternative excipients or delivery methods not covered by the claims.
- The patent landscape in Russia aligns with broader Eurasian regional patents, suggesting potential patent applications in EAPO or other markets.
Summary table of key patent elements
| Element |
Details |
| Filing date |
Approximately 2019 |
| Patent number |
RU2708254 |
| Patent validity |
Expected until 2039, subject to maintenance |
| Claims scope |
Formulation composition, manufacturing process, use |
| Geographic scope |
Russia, with family filings in Eurasia |
| Related patents |
Similar formulations, variations in excipients |
Key Takeaways
- RU2708254 claims a specific pharmaceutical formulation and associated manufacturing process.
- The main patent protection covers a narrow but strategically valuable scope related to a unique combination of ingredients.
- The patent's claims have been crafted to avoid prior art and secure exclusivity in Russia until 2039.
- Competing entities should analyze claim language carefully to avoid infringement or identify loopholes.
- The patent landscape indicates ongoing R&D activity, with potential for regional patent filings expanding coverage.
FAQs
Q1: Can the claims of RU2708254 be easily challenged?
Yes, if prior art demonstrates the claimed formulation or process is not novel or inventive, the patent could be invalidated.
Q2: Does the patent protect methods of use?
Only if such methods are explicitly claimed; in most cases, RU2708254 protects formulations and manufacturing steps.
Q3: How does RU2708254 compare with international patents?
It is narrower in scope but may be strategically complementary if licensed or used in regional markets within Eurasia.
Q4: Are there potential workarounds for competitors?
Yes, by altering active ingredient ratios, excipients, or manufacturing methods outside the scope of claims.
Q5: What future patent opportunities exist?
Filing for improved formulations, alternative delivery systems, or methods of use that do not infringe the current patent.
References
[1] Russian patent database, Federal Institute of Industrial Property (FIPS).
[2] Espacenet patent database.
[3] PatBase patent family analysis.
[4] Eurasian Patent Office (EAPO) filings.
